Cochrane plans to allay fears over industry influence

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional

2 Citations (Scopus)


The leadership of the global Cochrane Collaboration is acting to allay fears that drug company funding could damage the organisation's independence and credibility.

Jim Neilson, a joint chairman of the collaboration, told the BMJ that the collaboration's international steering group was taking the issue seriously. “We are very conscious of the need to maintain the credibility and unbiased nature of Cochrane reviews.”
Original languageEnglish
Pages (from-to)1005-1005
Number of pages1
JournalBMJ (Clinical research ed.)
Issue number7422
Publication statusPublished - 1 Nov 2003


Dive into the research topics of 'Cochrane plans to allay fears over industry influence'. Together they form a unique fingerprint.

Cite this